Tokyo -- Kaneka Corporation will appeal a September 2, 2026 ruling by the U.S. District Court for the Eastern District of New York that invalidated its U.S. Patent No. 7,829,080 covering reduced coenzyme Q10, known as ubiquinol.

Jiaxing, China – September 09, 2026 -- The U.S. District Court for the Eastern District of New York has invalidated two patent claims Kaneka Corporation asserted against Cocrystal Technology (Jiaxing) Co., Ltd., ending a nearly three-year dispute and clearing the way for unrestricted U.S. sales of Cocrystal Tech's ubiquinol ingredient, now branded CrysQnolTM.